Digital Transformation and Emerging Technologies in the Healthcare Industry

Reasons to buy the ‘Digital Transformation and Emerging Technologies in the Healthcare Industry’ report:

• Benchmark the level of business readiness and technology adoption.
• Gain a deeper understanding of the business functions affected the most by digital transformation.
• Identify and assess barriers to adopting emerging technologies.
• Define the critical requirements for success.
• Determine the importance of emerging technologies to the pharmaceutical industry.
• Evaluate current levels of investment and identify both present and future investment priorities.
• Analyze the impact of COVID-19, inflation, and other factors on digitalization efforts.
• Explore the impact of emerging technologies on the pharmaceutical value chain.
• Assess the role of digital transformation in sustaining competitive advantage.

How is our ‘Digital Transformation and Emerging Technologies in the Healthcare Industry’ report unique from other reports in the market?

• Stay up to date on the scope, challenges, and essentials for the digital transformation within the healthcare industry.
• Explore how innovations are transforming the healthcare industry and what impact these technologies will have on the sector in the near future.
• Develop and design your corporate strategies through an in-house expert analysis of the key factors of digital transformation and emerging technology in the healthcare sector.
• Develop business strategies by understanding the key factors of digital transformation and emerging technology in the healthcare sector.
• Identify emerging industry trends in the uptake of emerging technologies to gain a competitive advantage.

We recommend this valuable source of information to anyone involved in:

• ​​​Healthcare and Pharma Technology Leaders and Start-ups
  • Leading AI Adopters in Healthcare
  • Specialist AI Vendors in Healthcare
• Distributors, Pharmacies, Research Scientists, and Healthcare IT Specialists
• Executives Leading the Digital Healthcare Segment
• Healthcare Supplies and Manufacturing (Pharma and Medical Devices)
• Products Pipeline Research and Drug Development/Clinical Research Organisations
• Consulting and Professional Services (e.g., Investment Companies, Investment Banks, Equity Companies, etc.)
• Financial Institutions (Investors in Pharma/Biotech, Pricing Consultancies)/Parallel Trade Organisations

To Get a Snapshot of the Digital Transformation and Emerging Technologies in the Healthcare Industry Report

Download a Free Report Sample

Digital Transformation and Emerging Technologies in the Healthcare Industry Report Overview

Declining profit margins, increasing cost pressures, and the need to both replenish pipelines and maximize peak sales are driving the ongoing shifts in the pharmaceutical industry. Although adopting innovative technologies is seen as a key strategy to mitigate these challenges, the digitalization process is complex, time-consuming, and requires significant investment, along with sustained commitment and transparent dialogue with various stakeholders, including employees, investors, and regulators.

In the ‘Digital Transformation and Emerging Technologies in the Healthcare Industry’ report, GlobalData examines the progress of digital transformation in the pharmaceutical industry. It assesses the industry’s preparedness to embrace innovation, explores the challenges and opportunities associated with digital transformation as well as highlights current and emerging trends in technology-related investments.

Buy the Full Report for More Insights into the Digital Transformation and Emerging Technologies in Healthcare Industry

Download a Free Report Sample

Digital Transformation - Emerging Technologies

recruitment by analyzing the data. Additionally, in clinical practice, AI-assisted tools can improve diagnostic imaging, surgical operations, enhanced disease detection, and patient triaging.

Emerging Technologies in Digital Transformation

Buy the Full Report for More Emerging Technology Insights into the Digital Transformation Theme

Download a Free Report Sample

Digital Transformation Strategies

For the pharmaceutical sector, digital transformation is imperative to enhance product development and research processes and ultimately to achieve sustainable growth. A gradually increasing percentage of pharma industry professionals are willing to implement digital transformation or have intentions to implement it as such. This suggests that more organizations see innovation adoption as fundamental for enhancing efficiency, responding to customer expectations, gaining a competitive edge, or building resilience.

Emerging technologies are also set to continue to play a key role in enhancing the marketing and sales process. By improving data collection and processing, timely insights on users’ behaviors and preferences can be obtained, resulting in more effective marketing campaigns or more accurate sales forecasts.

Buy the Full Report for More Digital Transformation Strategy Insights

Download a Free Report Sample

Digital Transformation Objectives

By leveraging innovative technologies, businesses can optimize workflows, streamline processes, and enhance end-user experiences, as a result helping to foster innovative mindset, competitiveness, and ability to respond to any changes in ever-changing business environments. Pharma industry professionals consider operations enablement and innovation as the main scope of digital transformation in 2024. For example, operations enablement can be achieved by automating routine tasks and attaining real-time insights to enable better decision-making to respond to any operational disruptions or challenges.

Scope of Digital Transformations – All Respondents, 2024

Buy the Full Report for More Digital Transformation Objective Insights

Download a Free Report Sample

Key Highlights

• Digital transformation is steadily advancing in the pharmaceutical industry.
• Operations enablement and innovation continued to be the main purpose of digital transformation in the healthcare sector.
• The majority of survey respondents were optimistic about the growth of digital transformation in their organizations.
• Lack of specific skills and talents, insufficient funding, and organizational silos are hindering emerging technologies uptake.
• Digital privacy and data security issues and increased cyber risks were the leading concerns associated with digital transformation.
• Building a constant culture of change and strong leadership were seen as the most important drivers of a successful digital transformation.
• Pharma executives are prioritizing Big Data, digital media, and cloud computing for current investment, and AI, Big Data, and digital media for the near future.
• AI and Big Data are set to remain the most disruptive powers in the healthcare sector for the next two years.
• Inflation can act as both an obstacle and an enabler for digital transformation.